Morningstar
•
Nov 05, 2026
Medtronic plc: Medtronic Is Well Positioned for 2027 Thanks to Its Lineup of New Products
Summary
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Market Update: CAKE, COP, DGX, EMR, GPN, HON, MSI, YUM, VRSK
Nov 06, 2026
•
YUM, MSI, GPN, DGX, COP, HON, CAKE, EMR, VRSK
Analyst Report: AbbVie Inc
Nov 06, 2026
•
ABBV
Market Digest: FIS, MCD, SPGI, NUE, SMCI, APO, ABBV, PPC, APP
Nov 06, 2026
•
APO, APP, FIS, PPC, SMCI, SPGI, ABBV, MCD, NUE
Analyst Report: Becton, Dickinson and Company
Nov 06, 2026
•
BDX
Analyst Report: Kimberly-Clark Corporation
Nov 05, 2026
•
KMB
Analyst Profile
Debbie S. Wang
Senior Equity Analyst
Debbie Wang is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers the medical-device industry. Previously, she was an associate director of equity analysis for Morningstar, leading the healthcare team.Before joining Morningstar in 2002, Wang was a vice president and senior brand strategist for Leo Burnett. During her tenure at Leo Burnett, she led brand strategy on a variety of accounts, including Allstate, Amoco, McDonald/s, Heinz, Smucker’s, Pepto-Bismol, and Celebrex.Wang holds a bachelor’s degree in anthropology from Colgate University and a master’s degree in business administration from the University of Chicago Booth School of Business.
